Greenspec to Support Sales and Service of sp3’s Model 655 and Model 665 Hot Filament CVD Diamond Deposition Reactors

sp3 Diamond Technologies, Inc. (sp3), a leading supplier of diamond products, equipment and services, today announced that it has selected Greenspec, Inc. as a sales and services representative for the Republic of Korea. The relationship will allow Greenspec to actively market, sell and service sp3’s CVD diamond deposition reactors, including the single-chamber Model 655 and dual-chamber Model 665. Greenspec has already completed training on sp3’s diamond deposition reactors at sp3’s Santa Clara, Calif. manufacturing facility.

“We see strong potential for the adoption of CVD diamond in Korea for both high-technology applications, such as diamond-coated electrodes and wafer-scale diamond, as well as cutting tool applications,” said Dwain Aidala, president and COO of sp3 Diamond Technologies. “Greenspec offers us an important, local resource to support our anticipated growth in Korea. Its ability to offer local service, in particular its extensive direct experience with complex semiconductor manufacturing equipment, combined with a sales force that understands the technology and markets triggered the relationship. These attributes, along with the ability to communicate the value CVD diamond can bring to key local markets, made Greenspec an ideal choice to represent sp3.”

Greenspec and sp3 have an existing Korean Hot Filament CVD Diamond Reactor customer that will be supported by Greenspec’s local service. Additionally, Greenspec’s relationships with local industries and government laboratories are expected to enhance sp3’s CVD diamond penetration of the Korean market.

sp3 Diamond Technologies provides CVD diamond deposition reactors and diamond-based solutions for electronics thermal management and enhanced cutting surfaces to companies worldwide, across a broad spectrum of industries. By supplying wafer-scale diamond-on-substrate products and services utilizing nano and microcrystalline diamond morphology, sp3 is expanding the commercial reach of polycrystalline CVD diamond.

sp3 understands diamond and manufacturing equipment, as well as the cost, reliability and quality needs of its customers. In addition to running its own CVD diamond manufacturing facilities, sp3 is unique in selling its hot filament CVD reactors so customers can manufacture their own CVD diamond in-house.

Founded in 1993 and headquartered in Santa Clara, California, USA, sp3 Diamond Technologies is a subsidiary of sp3 Inc., a privately-owned, full service provider of products and services relating to thin-film diamond deposition and thick-film polycrystalline diamond materials. sp3 Inc. and its operational units have deposited diamond on over one and a half million cutting tools and completed more than 18,000 successful diamond deposition runs.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    sp3. (2019, February 13). Greenspec to Support Sales and Service of sp3’s Model 655 and Model 665 Hot Filament CVD Diamond Deposition Reactors. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=20847.

  • MLA

    sp3. "Greenspec to Support Sales and Service of sp3’s Model 655 and Model 665 Hot Filament CVD Diamond Deposition Reactors". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=20847>.

  • Chicago

    sp3. "Greenspec to Support Sales and Service of sp3’s Model 655 and Model 665 Hot Filament CVD Diamond Deposition Reactors". AZoNano. https://www.azonano.com/news.aspx?newsID=20847. (accessed November 21, 2024).

  • Harvard

    sp3. 2019. Greenspec to Support Sales and Service of sp3’s Model 655 and Model 665 Hot Filament CVD Diamond Deposition Reactors. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=20847.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.